BamSEC and AlphaSense Join Forces
Learn More

Gyre Therapeutics Inc.

NASDAQ: GYRE    
Share price (12/24/24): $11.90    
Market cap (12/24/24): $1.113 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-3 41 pages Definitions and Incorporation by Reference
12/34/56
EX-4.4
from S-3 41 pages Definitions and Incorporation by Reference
12/34/56
EX-4.1
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from S-8 21 pages Amended and Restated Bylaws of Gyre Therapeutics, Inc
12/34/56
EX-4.6
from S-8 5 pages Gyre Therapeutics, Inc. Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-4.4
from S-8 2 pages Third Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Catalyst Biosciences, Inc
12/34/56
EX-4.1
from 8-K 12 pages Catalyst Biosciences, Inc. Warrant to Purchase Series X Convertible Preferred Stock
12/34/56
EX-4.5
from S-3 44 pages Catalyst Biosciences, Inc. and , as Trustee, Indenture Dated as of Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939, as Amended, and the Indenture
12/34/56
EX-4.1
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3 44 pages Catalyst Biosciences, Inc. and , as Trustee, Indenture Dated as of Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939, as Amended, and the Indenture
12/34/56
EX-4.5
from S-3 55 pages Catalyst Biosciences, Inc. and Trustee Indenture Dated as of Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939, as Amended, and the Indenture
12/34/56
EX-4.5
from S-1/A 22 pages Common Stock Purchase Warrant Catalyst Biosciences, Inc
12/34/56
EX-4.6
from S-3 55 pages Catalyst Biosciences, Inc. and Trustee Indenture Dated as of Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939, as Amended, and the Indenture
12/34/56
EX-4.5
from 10-K 9 pages Warrant to Purchase Stock of Catalyst Biosciences, Inc
12/34/56
EX-4.4
from 10-K 9 pages Warrant to Purchase Stock of Catalyst Biosciences, Inc
12/34/56
EX-4.3
from 10-K 11 pages Warrant to Purchase Stock
12/34/56
EX-4.1
from 8-K/A 79 pages Targacept, Inc., as Issuer, and American Stock Transfer & Trust Company, LLC, Trustee Indenture Dated as of August 19, 2015 Providing for the Issuance of Redeemable Convertible Notes Due 2018
12/34/56
EX-4.5
from S-4/A 7 pages Warrant to Purchase Stock of Catalyst Biosciences, Inc
12/34/56
EX-4.4
from S-4/A 6 pages Convertible Promissory Note
12/34/56
EX-4.7
from S-3 54 pages Targacept, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56